CVS Health Corp (NYSE:CVS) on Wednesday reported better-than-expected third-quarter earnings and raised its annual guidance.

CVS is reaching significant price levels. See if it is worth your attention here

The company reported sales of $102.87 billion, beating the consensus of $98.84 billion. Total revenues increased 7.8% year-over-year, driven by revenue growth across all segments.

Adjusted earnings of $1.60 per share also beat the analyst estimate of $1.37. Third quarter GAAP diluted loss per share of $3.13, which included $5.7 billion goodwill impairment charge related to the Health Care Delivery reporting unit.

Adjusted operating income increased 35.8% to $3.46 billion, driven by an increase in the Health Care Benefits segment, partially offset by declines in the Health Services and Pharmacy & Consumer Wellness segments.

Also Read: EMD Serono, CVS Health To Partner On TrumpRx Fertility Program Launching In 2026

Revenues in the Health Care Benefits ...